16-Mar-16 Bain Capital LLC is paying USD150 mn for control of China-focused hospital operator Asia Pacific Medical Group, in the first deal for the private-equity firm’s new Asia fund. APMG provides primary care and specialty services, with a focus on neurology and oncology, and has four hospitals in China and a chain of clinics in Singapore and Malaysia. [image: Bain Capital LLC]
Read More
14-Mar-16 "China's ZTE Corp has announced the release of its mHealth product: all-in-one physical examination terminals, with both professional and home editions available.
The health terminal is a multi-parameter instrument with integrated functions for blood pressure, ECG, blood oxygen saturation and urine test, and actively collaborates with a back-end cloud." [image: ZTE]
08-Mar-16 According to a circular issued by China's State Council, generic drugs already available on the market should be assessed on whether they are consistent with brand-name drugs, and if they could be used clinically. Crucially, generics that pass the assessment will be included under national insurance coverage. [image: People's Daily Online]
Read More
02-Mar-16 Investors have become increasingly chittery about China’s investment prospects. Almost all the big “Western” hospital chains have steered clear of Emerging Markets. The biggest of all, Hospital Corporation of America, has only gone as far as London. Private hospitals in Emerging Markets need links to local politicians and governments to win projects. [image: World Crunch]
Read More
02-Mar-16 Australia's Ramsay Health Care has scrapped its proposed hospital joint venture in western China because several conditions weren't met. In total, the JV was expected to cover five hospitals with approximately 2,300 beds and a focus on women's health, mental health, and traditional Chinese medicine. [image: Ramsay Health Care]
Read MoreGGM is a research and advisory firm helping clients grow profitably in international markets.
We believe the only way to understand a market properly is on the ground. Intelligence from our in-country consultants gives you a competitive advantage in Asia, Latam, the Middle East & Africa, Europe and North America.
Our clients benefit from accurate data, reliable insights and strategic advice, giving them the confidence to make better business decisions and succeed in their global growth markets.
Successful track record in your sector since 1992
In-country research consultants in over 40 markets
Value for money - quality results at affordable rates
Work led by senior directors with >20 years experience
Proven frameworks for data analysis and strategy
Pragmatic advice based on accurate data and reliable insights
Find out more about our international market intelligence and strategy services
Get in touch to discuss your growth markets research and advisory needs:
Email: info@ggmkts.com
Follow us: